ACM
GSK icon

Allred Capital Management’s GSK GSK Stock Holding History

Allred Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$22.3K – 420
2021
Q1 		$22.3K Buy
+500
New +$22.7K 0.01% 519
2020
Q1 		– Sell
-3,180
Closed -$187K – 361
2019
Q4 		$187K Sell
3,180
-2,078
-40% -$116K 0.1% 155
2019
Q3 		$278K Sell
5,258
-861
-14% -$44.3K 0.17% 133
2019
Q2 		$313K Sell
6,119
-87
-1% -$4.37K 0.18% 130
2019
Q1 		$325K Buy
+6,206
New +$310K 0.19% 135

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Allred Capital Management's GSK Position: Q2 2021 in Review

Allred Capital Management sold out of GSK (GSK) in Q2 2021, closing a stake of 500 shares — an estimated $22.3K sold.

Allred Capital Management first reported a position in GSK in Q1 2019 and held it in 5 quarters. The position peaked at $325K in Q1 2019. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

  • Allred Capital Management reported no remaining GSK position as of Q2 2021 after selling out during the quarter.
  • Allred Capital Management sold 500 GSK shares in Q2 2021, an estimated $22.3K.
  • Allred Capital Management first reported a position in GSK in Q1 2019 and held it in 5 quarters.
  • Allred Capital Management's GSK position peaked at $325K in Q1 2019.
  • 798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Allred Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.